Industries
Hospital Operations
All research in Hospital Operations — 3 reports.
42/100
Universal Health Services Value-Investing Deep-Dive
Universal Health Services is the second-largest private hospital operator in the United States, with a high-quality behavioral health segment and a discounted valuation. The core thesis is that its cash flows are real and its PE of about 6.1x is low, but the company is heavily exposed to government reimbursement and litigation risk. Research rating Cautious Buy: a durable but imperfect value opportunity, best bought with discipline around the $125 to $140 fair buy range.
41/100
DaVita In-Depth Value Investing Research
The leading U.S. dialysis-center chain for end-stage renal disease, with inelastic demand, strong cash flow, and outstanding buyback execution, yet nearly all of its profit depends on high-priced commercial insurance while it carries negative book equity and net leverage above 3x. At roughly $194 the stock sits between the conservative and neutral valuations, leaving too thin a margin of safety. We assign a Watch rating, with an ideal buy range of $150-170.
46/100
HCA Healthcare: A Long-Term Owner's View
HCA is the largest integrated hospital network in the United States, with 2025 revenue of $75.6 billion, Adjusted EBITDA of $15.6 billion, and FCF of $7.69 billion. Its cash flow is real, but leverage is high, with net debt of $48.0 billion, and the business is highly sensitive to regulation. Research rating Watch: at roughly $394, the stock sits near the upper end of the conservative range, with no obvious margin of safety.